跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ESTIRIPENTOL BILLEV 250 MG POLVO PARA SUSPENSION ORAL EN SOBRES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ESTIRIPENTOL BILLEV 250 MG POLVO PARA SUSPENSION ORAL EN SOBRES EFG
Approved
STANDARD
ESTIRIPENTOL BILLEV 250 MG POLVO PARA SUSPENSION ORAL EN SOBRES EFG
Billev Pharma Aps
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 2, 2025
Approval ID
8fba559c6d9f0542
Company
Billev Pharma Aps
Type
Standard
Approval Details
Approval Id
8fba559c6d9f0542
Drug Cima Aemps Name
ESTIRIPENTOL BILLEV 250 MG POLVO PARA SUSPENSION ORAL EN SOBRES EFG
Register Number
90249
Holder Company Name
Billev Pharma Aps
Marketing Company Name
Billev Pharma Aps
Holder Company Detail Path
/organization/billev-pharma-aps
Marketing Company Detail Path
/organization/billev-pharma-aps
Authorization Date
2025-04-02
Dosage Form
POLVO PARA SUSPENSIÓN ORAL
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Billev Pharma Aps
Company Detail Path
/organization/billev-pharma-aps
Company Information
Pharmaceutical Company Name
BILLEV PHARMA ApS
Country Name
Denmark
Website
https://billevpharma.dk
Active Ingredients
ESTIRIPENTOL
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 2, 2025
Approval ID
8fba559c6d9f0542
Type
Standard
Back to CIMA-AEMPS Approvals